Prof. Erich Seifritz, MD, Director, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich

Prof. Dr. Boris Quednow, Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich

Prof. Birgit Kleim, PhD, Division of Clinical Psychology and Psychotherapy, University Hospital of Psychiatry Zurich

Prof. Dr. Andrew Gloster, Clinical Psychology and Intervention Science, Faculty of Psychology, University of Basel

PD Dr. Kurt Stocker, Project Leader Consciousness Studies, Chair of Cognitive Science, ETH Zurich

Prof. Hanspeter Landolt, PhD, Institute of Pharmacology and Toxicology, University of Zurich

Prof. Thomas Krämer, Forensic Pharmacology and Toxicology, University of Zurich

Prof. Michael Ashton, PhD, Department of Pharmacology, University of Gothenburg, Sweden

Maxim Puchkov, PhD, Department of Pharmaceutical Sciences, University of Basel

Roch Ogier, MD, PhD, Therapy Development Accelerator, University of Zurich

Davor Kosanic, PhD, Innovation Projects, EPFL

Michael Kometer, PhD, Co-Founder & Managing Director, Neuronomics AG

Robin von Rotz, PhD candidate, University of Zurich

David Andel, Co-Founder & CTO, Neuronomics AG

Ansgar Rougemont-Bücking, MD, Department of Neurosciences and Movement Science, Faculty of Science and Medicine, University of Fribourg

Heiner Dörfler, MD, Praxis für Humanistische Psychotherapie, Zürich